Mehta Ruby - Center for Drug Evaluation and Research Office of New Drugs Office of Inflammation and Immunity Division of Hepatology and Nutrition, US Food and Drug Administration

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

VARIABILITY IN REFERENCE RANGES OF HEPATIC BIOCHEMICAL TESTS IN PEDIATRIC POPULATIONS: IMPLICATIONS FOR MONITORING AND ASSESSMENT OF DRUG INDUCED LIVER INJURY

Arie Regev,John Marcinak, Linyun Zhou, Funan Huang,Ruby Mehta,Benjamin Shneider,Jean Molleston, Kathy Kordy, Eric Maller,William Treem, Linda Wang, Deepa Chand, David Brott,James Lewis

HEPATOLOGY (2024): S930-S931

引用0浏览0引用

Nonalcoholic Steatohepatitis: Current Thinking from the Division of Hepatology and Nutrition at the Food and Drug Administration

Frank A. Anania,Lara Dimick-Santos,Ruby Mehta,Joseph Toerner,Julie Beitz

Hepatology（2021）

引用36浏览0WOS引用

Nonalcoholic Steatohepatitis: Current Thinking From the D ivision of H epatology and N utrition at the F ood and D rug A ..

Frank A. Anania,Lara Dimick‐Santos,Ruby Mehta,Joseph Toerner,Julie Beitz

Hepatology（2021）

引用23浏览0引用

Attribution of Nonalcoholic Steatohepatitis As an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum

Mazen Noureddin,Jean L. Chan,Katherine Barradas,Lara Dimick-Santos,Elmer Schabel,Stephanie O. Omokaro,Frank A. Anania,Robert P. Myers,Veronica Miller,Arun J. Sanyal,Naga Chalasani,Jasmohan Bajaj,Annalisa Berzigotti,Pascal Birman,Jaime Bosch, Ashley Brower, Dania Calboli, William Charlton,Klara Dickinson,Claudia Filozof,Mikael F. Forsgren,Michael Fuchs,Guadalupe Garcia-Tsao,Juan Gonzalez-Abraldes,Hans-Juergen Gruss, Morten Hansen, Suneil Hosman,Joanne Imperial,David Jones,Gadi Lalazar,Olof Dahlqvist Leinhard,Erica Lyons, Brian McColgan,Ruby Mehta,Peter Mesenbrink,Rob Myers, Veronica Pei,Vlad Ratziu,Arie Regev, Robert Riccio,Arun Sanyal, Suna Seo,Alastair Smith,Peter Szitanyi,Peter Traber

Gastroenterology（2020）

引用16浏览0WOS引用

Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease

Miriam B. Vos,Lara Dimick-Santos,Ruby Mehta,Stephanie O. Omokaro, Johannes Taminiau,Elmer Schabel,David E. Kleiner,Peter Szitanyi,Piotr Socha,Jeffrey B. Schwimmer,Stephanie Noviello, Debra G. Silberg,Richard Torstenson,Veronica Miller,Joel E. Lavine,Nathalie Adda, William Baldyga,Rajarshi Banerjee,Cynthia Behling,Sherif Boulos, Gary Burgess, Dania Calboli,Edgar Charles,Rose Christian, Claude Cohen-Bacrie, Doina Cosma-Roman, Claus-Peter Danzer, Ingrid Delaet, Mark Delegge, Nicholas DiProspero, Kathleen Donohue,Laurent Fischer,Emer Fitzpatrick, Michael Fried,David Hagerty, Paula Hale, Keri Hildick,Dean Hum,Khurram Jamil,Lijuan Jiang,Saul Karpen,Matt Kelly,Rohit Kohli,Kattayoun Kordy, Nancy Krieger,Joel Lavine,Lois Lee,Eric Lefebvre,Patricia Lopez,Erica Lyons,Laura Malahias,Sophie Megnien,Peter Mesenbrink, Pansy Minnick, Christine Murray, Tien Nghiem, Nikki Nicholson,Wenjie Pang, Lisa Percival, Dan Peres, Margaret Powell, Dragos Roman, Mark Root, Claire Sampson,Arun Sanyal,Kathleen Schwarz,Star Seyedkazemi,David Shapiro,Reshma Shringarpure, Debra Silberg, Edward Smith,Robert Squires,William Treem,Pamela Vig,Miriam Vos,Mason Yamashita, Michael Zemel

Gastroenterology（2019）

引用14浏览0WOS引用

Endpoints in the Design of Clinical Trials for Primary Sclerosing Cholangitis

Cyriel Y. Ponsioen,Keith D. Lindor,Ruby Mehta,Lara Dimick-Santos

Hepatology (Baltimore, Md)（2018）

引用6浏览0WOS引用

Review article: therapeutic bile acids and the risks for hepatotoxicity

K. Ashby, E. E. Navarro Almario,W. Tong,Jürgen Borlak,R. Mehta,Minjun Chen

ALIMENTARY PHARMACOLOGY & THERAPEUTICS（2018）

引用47浏览0WOS引用

Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations from the Liver Forum

Yuval A. Patel,Joanne C. Imperial,Andrew J. Muir,Quentin M. Anstee,David Debrota,Lara Dimick-Santos,Claudia Filozof,Ruby Mehta,Arun J. Sanyal,Elmer Schabel,Brent A. Neuschwander-Tetri,Veronica Miller

Gastroenterology（2017）

引用25浏览0WOS引用

DOSING CONSIDERATIONS FOR OBETICHOLIC ACID (OCA) IN THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC)

D. Marathe,Y. Yang, E. Shang,S. Li,P. Zhao,S. -C. Lee,R. Mehta, S. O. Omokaro, L. Dimicksantos, A. Davis-Williams,J. Meyer, A. Egan, D. Roman,E. D. Bashaw,V. Sinha,N. Mehrotra

CLINICAL PHARMACOLOGY & THERAPEUTICSno. S1 (2017): S77-S77

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn